The World Health Organisation has added GLP-1 drugs to treat diabetes, as well as treatments for cystic fibrosis and cancer, to its essential medicines list, aiming to boost global access to these often-costly medications.
The catalogue, now consisting of 523 medicines for adults and 374 for children, identifies drugs which the WHO believes should be available in all functioning health systems.